Literature DB >> 9215336

The burden of Parkinson's disease on society, family, and the individual.

K Whetten-Goldstein1, F Sloan, E Kulas, T Cutson, M Schenkman.   

Abstract

OBJECTIVE: To examine the burden of Parkinson's Disease (PD) on society, family, and the individual.
SETTING: In-home interviews in Central North Carolina.
DESIGN: A cross-sectional, descriptive study. PARTICIPANTS: A total of 109 people with PD. MEASURES: Standard instruments used to assess income, health status, health-related costs, and household activities. SAMPLE: The sample was weighted toward individuals who were within the first 5 years of post-PD diagnosis.
RESULTS: The total per capita societal burden was approximately $6000 per year, the greatest single element of which was compensation for earnings loss for those less than age 65. Government insurance covered 85% of our sample. The largest components of family burden were the burden of providing informal caregiving and that of earnings loss. Spouses providing informal care did so a mean of 22 hours per week. Compared with a random sample of older people, our respondents spent much less time on house and yard work.
CONCLUSION: The direct costs of the disease reflect a small portion of the burden. The hidden costs, in the form of lost wages, informal care, and changing roles are substantial. Their magnitude is even more important when we consider that the family generally lives on a fixed income, and the caregiver is an older aged spouse. Medical practitioners will best be able to intervene if they look holistically at the patient with this disease. When treating symptoms themselves, practitioners need to be aware of the high level of pain, fatigue, and depression associated with PD, even in the early stages. The results demonstrate clearly that family relationships are affected early, indicating the importance of providing early referrals to services such as home health, social workers/counseling, and well as PD support groups.

Entities:  

Mesh:

Year:  1997        PMID: 9215336     DOI: 10.1111/j.1532-5415.1997.tb01512.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  50 in total

Review 1.  Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias.

Authors:  R C Dodel; K Berger; W H Oertel
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 2.  Measurement of quality of life in neurodegenerative disorders.

Authors:  M D Welsh
Journal:  Curr Neurol Neurosci Rep       Date:  2001-07       Impact factor: 5.081

3.  The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis.

Authors:  R C Dodel; M Singer; R Köhne-Volland; T Szucs; B Rathay; E Scholz; W H Oertel
Journal:  Pharmacoeconomics       Date:  1998-09       Impact factor: 4.981

4.  [Analysis of direct costs in therapy of Parkinson disease].

Authors:  S Keller; T Kessler; Th Meuser; W Fogel; D Bremen; W H Jost
Journal:  Nervenarzt       Date:  2003-12       Impact factor: 1.214

5.  Costs of illness in a Russian cohort of patients with Parkinson's disease.

Authors:  Yaroslav Winter; Sonja von Campenhausen; Georgy Popov; Jens P Reese; Jens Klotsche; Kai Bötzel; Eugene Gusev; Wolfgang H Oertel; Richard Dodel; Alla Guekht
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

6.  Patient and caregiver perceptions of the social impact of advanced Parkinson's disease and dyskinesias.

Authors:  Alexander Khlebtovsky; Amihai Rigbi; Eldad Melamed; Ilan Ziv; Israel Steiner; Alona Gad; Ruth Djaldetti
Journal:  J Neural Transm (Vienna)       Date:  2012-03-22       Impact factor: 3.575

Review 7.  Depression and burden among the caregivers of visually impaired patients: a systematic review.

Authors:  Robin K Kuriakose; Zainab Khan; David R P Almeida; Puneet S Braich
Journal:  Int Ophthalmol       Date:  2016-07-29       Impact factor: 2.031

8.  Cost effectiveness of treatment of Parkinson's disease with entacapone in the United States.

Authors:  Cynthia S Palmer; Mark J C Nuijten; Jordana K Schmier; Prasun Subedi; Edward H Snyder
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

9.  Variables associated with physical health-related quality of life in Parkinson's disease patients presenting for deep brain stimulation.

Authors:  Alexandre Paim Diaz; Fernando Cini Freitas; Maria Emília de Oliveira Thais; Fernando Zanela da Silva Areas; Marcelo Liborio Schwarzbold; Rodrigo Debona; Jean Costa Nunes; Ricardo Guarnieri; Daniel Martinez-Ramirez; Rui Daniel Prediger; Aparna Wagle Shukla; Marcelo Neves Linhares; Roger Walz
Journal:  Neurol Sci       Date:  2016-07-25       Impact factor: 3.307

Review 10.  Viral parkinsonism.

Authors:  Haeman Jang; David A Boltz; Robert G Webster; Richard Jay Smeyne
Journal:  Biochim Biophys Acta       Date:  2008-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.